Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1971 1
1973 2
1976 5
1977 2
1978 2
1979 1
1980 1
1981 1
1982 1
1983 2
1984 2
1985 1
1986 1
1987 2
1988 2
1989 2
1990 2
1991 3
1992 3
1993 1
1994 1
1995 2
1996 3
1997 3
1998 2
1999 3
2000 3
2001 4
2002 4
2003 1
2004 3
2005 4
2006 1
2007 1
2008 4
2009 4
2010 5
2011 4
2012 5
2013 2
2014 7
2015 5
2016 4
2017 6
2018 7
2019 2
2020 6
2021 5
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators. Torres VE, et al. N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.
Senum SR, Li YSM, Benson KA, Joli G, Olinger E, Lavu S, Madsen CD, Gregory AV, Neatu R, Kline TL, Audrézet MP, Outeda P, Nau CB, Meijer E, Ali H, Steinman TI, Mrug M, Phelan PJ, Watnick TJ, Peters DJM, Ong ACM, Conlon PJ, Perrone RD, Cornec-Le Gall E, Hogan MC, Torres VE, Sayer JA; Genomics England Research Consortium, the HALT PKD, CRISP, DIPAK, ADPKD Modifier, and TAME PKD studies; Harris PC. Senum SR, et al. Among authors: steinman ti. Am J Hum Genet. 2022 Jan 6;109(1):136-156. doi: 10.1016/j.ajhg.2021.11.016. Epub 2021 Dec 9. Am J Hum Genet. 2022. PMID: 34890546 Free PMC article.
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC; Conference Participants. Chapman AB, et al. Kidney Int. 2015 Jul;88(1):17-27. doi: 10.1038/ki.2015.59. Epub 2015 Mar 18. Kidney Int. 2015. PMID: 25786098 Free PMC article.
Polycystic kidney disease: a 2011 update.
Steinman TI. Steinman TI. Curr Opin Nephrol Hypertens. 2012 Mar;21(2):189-94. doi: 10.1097/MNH.0b013e32835011a7. Curr Opin Nephrol Hypertens. 2012. PMID: 22274800 Review.
Catatonia in uremia.
Steinman TI, Yager HM. Steinman TI, et al. Ann Intern Med. 1978 Jul;89(1):74-5. doi: 10.7326/0003-4819-89-1-74. Ann Intern Med. 1978. PMID: 666193 No abstract available.
Pain management in polycystic kidney disease.
Bajwa ZH, Gupta S, Warfield CA, Steinman TI. Bajwa ZH, et al. Among authors: steinman ti. Kidney Int. 2001 Nov;60(5):1631-44. doi: 10.1046/j.1523-1755.2001.00985.x. Kidney Int. 2001. PMID: 11703580 Free article. Review.
Pain management in polycystic kidney disease.
Steinman TI. Steinman TI. Am J Kidney Dis. 2000 Apr;35(4):770-2. doi: 10.1016/s0272-6386(00)70029-1. Am J Kidney Dis. 2000. PMID: 10739803 No abstract available.
129 results